We currently do not have an experimentally validated explanation for this; however, although superficially similar (regarding high levels of 2HG as a result of an IDH mutation), IDH-mutant astrocytomas and oligodendrogliomas are otherwise clinically and molecularly distinct. The gene discussed is IDH2; the disease is astrocytoma (excluding glioblastoma).